NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 26 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $35,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,546,743 | $6,450,000 | 1.60% |
| TIGER MANAGEMENT L.L.C. | 650,915 | $2,714,000 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $15,564,000 | 0.66% |
| RA Capital Management | 612,863 | $2,556,000 | 0.33% |
| WALL STREET ASSOCIATES | 170,400 | $711,000 | 0.30% |
| Opaleye Management Inc. | 100,000 | $417,000 | 0.26% |
| Rock Springs Capital Management LP | 489,000 | $2,039,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 662,058 | $2,761,000 | 0.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 79,900 | $333,000 | 0.07% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 256,552 | $1,070,000 | 0.06% |